The inflammatory infiltrate in mammary carcinoma has been investigated for over 70 years (Underwood, 1974) , but its significance remains controversial. Recent in vitro experiments show that tumour-infiltrating lymphocytes have little or no cytotoxic activity against autologous tumour (Balch et al., 1990) , and that their function may be inhibited by tumour cells (Miescher et al., 1986) . On the other hand, inflammatory cells are a potentially important source of cytokines that may affect angiogenesis and of enzymes that digest the extracellular matrix and thus may affect tumour growth and metastasis. Different studies, even with multivariate analysis, have shown that intense inflammation in the tumour is associated with good prognosis (Rilke et al., 1991) , poor prognosis (Parl et al., 1982) or of no effect (Alderson et al., 1971; Roses et al., 1982) . Most studies have used a general measure of the amount of inflammation in the tumour and not attempted to look at different patterns of inflammation. The inflammatory infiltrate has been characterised using immunohistochemistry, but frozen sections have been used, and usually only the inflammation within the tumour has been studied. Few studies have compared inflammation in different histological types of carcinoma.
This study was prompted by our impression that the inflammation associated with invasive lobular carcinoma may resemble lymphocytic lobulitis. This was reinforced by a case report describing this association (Chetty and Butler, 1993) . Lymphocytic lobulitis is a recently recognized disorder of the breast characterised by perilobular and perivascular aggregates of B and T lymphocytes with increased expression of class II major histocompatibility antigens by the lobular and ductal epithelium (Lammie et al., 1991; Schwartz and Strauchen, 1990) . We have therefore compared the patterns of inflammation in invasive ductal and lobular carcinomas, both within the tumours and in the adjacent breast tissue.
Method
A total of 123 invasive carcinomas of the breast were studied consisting of two groups. Group 1 was composed of 73 consecutive patients with invasive carcinoma of all types seen over 6 months (January 1991 -June 1991 . Group 2 contained 50 consecutive patients with carcinomas showing features of invasive lobular carcinoma or mixed lobular and ductal carcinoma, selected from 349 invasive carcinomas seen over the subsequent 2 year period (July 1991 -June 1993 .
All patients were operated on and followed up in the Imperial Cancer Research Fund Clinical Oncology Breast Unit at Guy's Hospital. Patients with a previous carcinoma of the breast, or bilateral mammary carcinoma at presentation were excluded. The tumours were typed using Azzopardi's criteria (1979) . Tumours were classified as mixed if there was more than 10% of at least two tumour types. The following were recorded for each tumour: necrosis in the invasive tumour, invasion of lymphatics or blood vessels, the number of axillary lymph nodes examined and the number of these involved by tumour, tumour size (measured microscopically in tumours up to 20 mm across, and macroscopically in larger tumours). Only ductal carcinomas were graded using the modified Bloom and Richardson method (Elston and Ellis, 1991) . The inflammation was assessed in the first surgical specimen in patients undergoing more than one procedure, to avoid inflammation associated with previous surgery. The pattern of inflammatory infiltrate (a) within and (b) at the edge of the invasive tumour was noted as (i) diffuse in the stroma between tumour cells, or focal, (ii) around tumour islands, (iii) around vessels or (iv) around lobules. The intensity of each pattern of inflammatory infiltrate was graded as absent or minimal (0), mild (1), moderate (2) or marked (3). The intensity of inflammation around any carcinoma in situ, and the presence of inflammation elsewhere in the specimen was noted.
Comparisons between groups were made with the MannWhitney U-method, and correlation using Spearman's rank method. The Wilcoxon signed-rank test was used to analyse paired data.
Immunohistochemistry
Immunohistochemistry with a panel of antibodies and appropriate pretreatment (Table I) 
Results
The median age of the patients studied was 57 (range 27-87). An axillary clearance was performed in 115 patients with a median of 22 axillary lymph nodes examined (range 8 -50). A median of four sections of tumour were examined (range 1-12).
The 123 invasive carcinomas of the breast were typed and graded as follows: Group 1, 55 ductal (15 grade I, 25 grade II, 15 grade III), eight lobular, four tubular or cribriform, five mixed lobular and ductal, one mucoid; and group 2, 38 invasive lobular carcinoma and 12 mixed lobular and ductal carcinomas. In the subsequent analyses invasive tubular and cribriform carcinomas were grouped with invasive ductal grade I.
Normal breast There was minimal inflammation around normal breast ducts and lobules away from the tumour, for example in the quadrant sections in mastectomies.
Diffuse inflammation associated with tumour
The predominant pattern of inflammation within and at the edge of tumours was diffuse in the stroma between tumour cells (Table II) . In all tumour types the intensity of Focal inflammation Focal inflammation around tumour cells was uncommon. It was seen within only six tumours (two ductal, two lobular and two mixed ductal and lobular), and at the edge of 11 tumours (six ductal, three lobular and two mixed ductal and lobular).
Perilobular inflammation
In all histological tumour types perilobular inflammation was more marked at the edge than within the tumour (Table III; Wilcoxon statistic 570, P<0.001). The intensity of perilobular inflammation at the tumour edge was more marked in lobular than ductal carcinomas (P = 0.02, Mann -Whitney U). Perilobular inflammation increased with increasing grade of ductal carcinoma (p = 0.28, P= 0.02). The intensity of perilobular inflammation at the edge of invasive carcinomas decreased with the age of the patient in ductal carcinomas (p=-0.53, P= 10-5), and mixed ductal and lobular carcinomas (p =-0.47, P = 0.03), but not in lobular carcinoma (p = -0.08). When moderate or marked perilobular inflammation was seen in ductal carcinomas there was usually moderate diffuse inflammation within the tumour. By contrast in lobular carcinomas with moderate or marked perilobular inflammation there was usually little or no diffuse inflammation within the tumour (Table IV) Table V and Figures 1 and 2) Figure 3 . Epithelial expression of HLA-DR was sometimes, but not always, associated with perilobular inflammation.
Discussion
The role of inflammation in tumours is controversial. Studies of the prognostic significance of inflammation in carcinoma of the breast, even with multivariate analysis, have produced conflicting results. A potential explanation of this is that few (Aaltoma et al., 1992) . Increasing inflammation with increasing histological grade has also been found by others (Aaltoma et al., 1992; Black et al., 1975; Elston et al., 1982; Fisher et al., 1983; Kurtz et al., 1990) . Most, but not all, studies have noted an association between inflammation and necrosis (Fisher et al., 1975; Black et al., 1975; Fisher et al., 1983; Aaltoma et al., 1992; An et al., 1987) . We found diffuse inflammation, histological grade and necrosis were interrelated in ductal carcinomas, but the correlation between the diffuse inflammation and necrosis was weak (p=0.31) so there must be factors in addition to necrosis causing the inflammation. The reported associations of inflammation with tumour expression of c-erbB-2 (Rilke et al., 1991) and colony-stimulating factor 1 (Scholl et al., 1994) are of potential interest. Immunohistochemistry showed that the diffuse inflammation in tumours was predominantly composed of T cells and macrophages. The majority of other studies have found that T cells outnumbered macrophages Bhan and DesMarais, 1983; Giorno, 1983; Hurliman et al., 1985; Kleist, 1987; Zuk and Walker, 1987) , but a significant minority, like us, found more macrophages than T cells (Gottlinger et al., 1985; Horny et al., 1986; van Ravenswaay et al., 1992) . Few B cells and few or no natural killer cells are consistent findings in the literature.
Focal inflammation close to and within tumour nests was uncommon in all tumour types in agreement with other series (Bhan et al., 1983; Gottlinger et al., 1985; Lwin et al., 1985) . It has been suggested that this low frequency of inflammatory cells close to the tumour cells indicates that the lymphocytes and macrophages do not represent an immune response to the tumour cells.
Perilobular inflammation was rarely seen within the tumour, probably owing to destruction of normal structures by the tumour. Black and Speer (1955) found marked inflammation in the tumour was associated with perilobular inflammation. They made no comment on histological tumour types, but the pattern described is similar to our findings in ductal carcinomas. By contrast in lobular carcinomas with perilobular inflammation there was usually little or no diffuse inflammation within the tumour. Immunohistochemistry showed that, in contrast to the diffuse inflammation, the perilobular inflammation was predominantly composed of B and T cells with few macrophages.
The relative absence of perivascular inflammation within the tumour may be because of differences between vessels within the tumour and normal vessels at the edge. There is evidence of differences between the endothelium in mammary carcinomas and in normal breast (Hagemeier et al., 1986; Wang et al., 1993) . Perivascular inflammation in breast cancer has been little studied. Black et al. (1975) found perivenous inflammation was associated with poorly differentiated tumours and longer survival in univariate analysis. It has been suggested that perivascular inflammation is a reflection of cell-mediated immunity by analogy with the changes in delayed type hypersensitivity reactions in the skin (Dvorak et al., 1981) . The perivascular inflammation, like the perilobular inflammation, was predominantly composed of B and T cells with few macrophages.
Normal breast epithelium shows no expression of HLA-DR (Bartek et al., 1987; Lucin et al., 1994) , except during late pregnancy and lactation (Bartek et al., 1987 
